「Integration of comprehensive Omics analysis into Precision Medicine in JAPAN」
・Taka-Aki Sato, Ph.D.
Director, Life Science Research Center, Shimadzu Corporation
Specially Appointed Professor, Director, Research and Development Center for Precision Medicine, University of Tsukuba
Professor, School of Integrative & Global Majors Ph.D. Program in Human Biology, University of Tsukuba.
Visiting professor, Laboratory of Translational Research, Institute for Molecular and Cellular Regulation
・Date:9th Dec. 2021 Tue 17:00～18:00
・ZOOM: No registration required
The Research and Development Center for Precision Medicine (PMC) was established as Japan’s first omics analysis center aiming to develop a $1000 genome sequencing technology. Using state-of-the-art technologies in Whole Genome Sequencing and Advanced Mass Spectrometry supported by Shimadzu Corporation, the Center aims to provide analytic and translational approaches to provide precise diagnosis of cancers and various diseases in a data-driven/evidence-based approach. The Center has been working with the Tsukuba Preventive Medicine Research Center, which offers a comprehensive medical examination utilizing the function of initiative prevention of medical research. In order to promote collaborations with leading domestic and international research institutions, the PMC is also active in cross-border multidisciplinary networking. The Center aims to establish a research infrastructure for the implementation and realization of Precision Medicine, toimprove/determine the best course of treatment for each individual. Furthermore, the spin-off biotech company, iLAC Co., Ltd., mainly focuses on integration of Precision Medicine, Humanoid Type of Robotics and COVID-19 WGS, contributing to the 4IR (Fourth Industrial Revolution).
・Contact: Institute for Molecular and Cellular Regulation, Gunma University
HatadaE-mail: hatada@gunma-u.ac.jp

Poster here →　佐藤先生セミナー2021英語_rev